Geoffrey R. Connors MD, FACP
Associate Professor of Medicine, Division of Pulmonary & Critical Care Medicine, University of Colorado School of Medicine, Aurora, ColoradoDr. Geoffrey Connors is a specialist in Internal Medicine, Pulmonary Disease, and Critical Care Medicine. Since 2017, he has been an Associate Professor of Medicine at the University of Colorado School of Medicine, Division of Pulmonary & Critical Care Medicine. In addition to his work as a Pulmonologist and Critical Care physician, Dr. Connors is the Program Director for the Internal Medicine Residency Training Program at the University of Colorado. Prior to coming to Colorado, Dr. Connors was Associate Professor of Medicine in the Section of Pulmonary, Critical Care, and Sleep Medicine at Yale University.
Dr. Connors received his medical degree from Tulane University School of Medicine in New Orleans. He underwent residency training in internal medicine at the University of Colorado School of Medicine in Denver, where he served as Chief Medical Resident. He completed a clinical and research fellowship in Pulmonary & Critical Care Medicine at the Johns Hopkins University School of Medicine in Baltimore.
He is a member of the American Thoracic Society and is board-certified in Internal Medicine, Pulmonary Medicine, and Critical Care Medicine.
Disclosures
Dr. Connors has no disclosures.
Recent Contributions to PracticeUpdate:
- Baseline Sex Differences in Pulmonary Arterial Hypertension Randomized Clinical Trials
- Adherence and Persistence to Single-Inhaler vs Multiple-Inhaler Triple Therapy for Asthma Management
- Improving Medication Adherence in Patients With Asthma
- Clinical Characteristics, Treatment Persistence, and Outcomes Among Patients With COPD Treated With Single- or Multiple-Inhaler Triple Therapy
- Chronic Thromboembolic Pulmonary Hypertension and Impairment After Pulmonary Embolism
- Closed-Loop Oxygen Control Improves Oxygen Therapy in Patients With Acute Hypoxemic Respiratory Failure
- Neoadjuvant Nivolumab Plus Chemotherapy in Resectable Lung Cancer
- Efficacy of Communication-Priming Intervention on Documented Goals-of-Care Discussions in Hospitalized Patients With Serious Illness
- Heparin in Critically Ill Patients With COVID-19
- Inhaled Budesonide for COVID-19 in High-Risk Patients